| 1st March 2017
The perpetually evolving nature of the healthcare market means that healthcare companies regularly find themselves in new and unfamiliar environments. As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Such mapping programs are designed with the objective of moving away from the traditionally ad-hoc nature of stakeholder engagement, and into the more forward-looking strategic engagement planning process.
Associate Consultant Pany Koizi talks through how to get the most out of the influence mapping process.
Beyond the visible organisational structure lies a more complex and intricate series of connections that flow across individuals, resources, and organisations. A stakeholder influence map visualises the myriad connections between stakeholders that dictate how a decision is made. In fluctuating market conditions, healthcare companies can use stakeholder influence maps as, quite simply, a roadmap to identify and reach the most influential stakeholders for the decision they want to target.
Stakeholder influence maps are constructed for any number of given decisions, but a common feature in each of these situations is reacting to a change in market dynamics. An example could be a pharmaceutical company exploiting a new indication for an existing drug. Given the new indication, the company is unlikely to be aware of the influencers within the new therapy area. Visualising the environment through a stakeholder influence map would allow the company to better identify and create more-informed engage plans for influential stakeholders.
In addition to analysing networks and identifying influential stakeholders, influence maps are designed to drive the strategic engagement planning process in three ways:
Communication is only as effective as the relevance of the message. A typical stakeholder map will also house information that allows team members to create a custom plan based on the drivers and pain points of individual stakeholders. A comprehensive stakeholder map will also outline preferred sources of information and mediums of communication for each stakeholder, further increasing the relevance and effectiveness of the message. It is also possible to analyse the prevalence of drivers or pain points within networks or micro-networks, allowing the optimisation of message for entire communities of stakeholders.
| 11th January 2018
Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns.
| 4th January 2018
Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and effectiveness, along with the formula for calculating profit and ROI.
| 5th December 2017
Pharma is making measured progress in its adoption of multichannel marketing. But can it actually measure success? And does it even know what good looks like? Chris Ross interviews Senior Consultant Paul Towney Jones to explore the risks and benefits of increased investment in MCM.